Alembic Pharmaceuticals Ltd.
APLLTD
104.65
0.00 (-4.60%)The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments.
Shareholding Pattern
| On | Ind. Pro. | Fore. Pro. | FII/FPI | Mutual Funds | Banks | Insurance | Others | Non/Institution |
|---|---|---|---|---|---|---|---|---|
| 2024-09 | 69.1 | 0.51 | 3.94 | 8.9 | 0.03 | 6.71 | 0.41 | 10.4 |
| 2024-06 | 69.1 | 0.51 | 4.32 | 8.05 | 0.03 | 6.98 | 0.41 | 10.6 |
| 2024-03 | 69.1 | 0.51 | 4.46 | 7.82 | 0.03 | 7.1 | 0.43 | 10.54 |
| 2023-12 | 69.1 | 0.51 | 4.52 | 7.71 | 0.03 | 6.52 | 0.24 | 11.37 |
| 2023-09 | 69.1 | 0.51 | 4.51 | 7.33 | 0.03 | 6.57 | 0.28 | 11.67 |
| 2023-06 | 69.1 | 0.51 | 4.34 | 6.64 | 0.03 | 6.74 | 0.24 | 12.4 |
| 2023-03 | 69.1 | 0.51 | 4.55 | 6.47 | 0.04 | 6.55 | 0.25 | 12.53 |
| 2022-12 | 69.1 | 0.51 | 4.99 | 5.87 | 0.04 | 6.6 | 0.25 | 12.64 |
| 2022-09 | 69.1 | 0.51 | 5.32 | 5.36 | 0.04 | 7.03 | 0.12 | 12.52 |
Results
| On | Income from Inv. | Int. on Bank Bal. | Int. on Advances | Other Int. | Interest Earned | Interest Exp. | Net Interest Income | Expenditure | Operating Income | Other Income | Prov. & Contingencies | PBT | Tax | PAT | Net Profit | Consolidated Net Profit | Adjusted EPS(Rs.) | Gross NPA | Gross NPA(%) | Net NPA | Net NPA(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09 | 0 | 0 | 0 | 0 | 1647.98 | 18.81 | 1629.17 | 1408.71 | 256.01 | 16.74 | 0 | 179.56 | 27.28 | 152.28 | 152.28 | 153.41 | 7.81 | 0 | 0% | 0 | 0% |
| 2024-06 | 0 | 0 | 0 | 0 | 1561.73 | 13.18 | 1548.55 | 1324.9 | 238.93 | 2.1 | 0 | 156.71 | 22.49 | 134.22 | 134.22 | 134.71 | 6.85 | 0 | 0% | 0 | 0% |
| 2024-03 | 0 | 0 | 0 | 0 | 1516.98 | 10.94 | 1506.04 | 1256.92 | 263.65 | 3.59 | 0 | 183.23 | 4.63 | 178.6 | 178.6 | 178.21 | 9.07 | 0 | 0% | 0 | 0% |
| 2023-12 | 0 | 0 | 0 | 0 | 1630.57 | 15.17 | 1615.4 | 1364.21 | 269.25 | 2.89 | 0 | 184.63 | 4.13 | 180.5 | 180.5 | 180.45 | 9.18 | 0 | 0% | 0 | 0% |
| 2023-09 | 0 | 0 | 0 | 0 | 1594.93 | 15.69 | 1579.24 | 1386.69 | 218.39 | 10.15 | 0 | 135.14 | -1.93 | 137.07 | 137.07 | 136.56 | 6.95 | 0 | 0% | 0 | 0% |
| 2023-06 | 0 | 0 | 0 | 0 | 1486.15 | 14.39 | 1471.76 | 1287.45 | 210.36 | 11.66 | 0 | 129.79 | 9.16 | 120.63 | 120.63 | 120.6 | 6.14 | 0 | 0% | 0 | 0% |
| 2023-03 | 0 | 0 | 0 | 0 | 1406.45 | 14.37 | 1392.08 | 1194.23 | 213.11 | 0.89 | 0 | 124.62 | -36.43 | 161.05 | 161.05 | 152.6 | 7.76 | 0 | 0% | 0 | 0% |
| 2022-12 | 0 | 0 | 0 | 0 | 1509.02 | 14.6 | 1494.42 | 1260.26 | 249.2 | 0.44 | 0 | 168.09 | 32.57 | 135.52 | 135.52 | 121.92 | 6.20 | 0 | 0% | 0 | 0% |
| 2022-09 | 0 | 0 | 0 | 0 | 1475.01 | 12.41 | 1462.6 | 1242.27 | 233.07 | 0.33 | 0 | 152.96 | 17.96 | 135 | 135 | 133.35 | 6.78 | 0 | 0% | 0 | 0% |
| 2022-06 | 0 | 0 | 0 | 0 | 1262.14 | 8.79 | 1253.35 | 1247.49 | 15.73 | 1.08 | 0 | -60.16 | -1.5 | -58.66 | -58.66 | -65.88 | -3.35 | 0 | 0% | 0 | 0% |